Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis, Severe Sepsis and Septic Shock Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Shock Shock, Septic Systemic Inflammatory Response Syndrome

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Wexner Medical Center at The Ohio State University

Columbus, Ohio, 43210, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult (≥18 to 90 years)
Patients presenting to the Emergency Department
CBC (Complete Blood Count) with differential testing performed and CPD data retrieved

Exclusion criteria

Previously enrolled in this study

Treatment and study plan

Primary outcomes

We are measuring CBC (complete blood count) and MNV (Mean Neutrophil Volume)

Time frame: approximately 10 months

Evaluate the clinical utility of CPD MNV as an aid in the diagnosis and risk assessment of Emergency Department patients for progression to sepsis, severe sepsis and septic shock.

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Registry information

Official study title

Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Acronym: Beckman

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Sep 5, 2014
Registry last updated: Nov 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting